- E-post
- mona.s.nilsen@uib.no
- Besøksadresse
-
Haukeland universitetssykehus, Laboratoriebygget
5009 Bergen - Postadresse
-
Postboks 7804
5020 Bergen
Forskergrupper
Kort info
Postdoktor hos forskningsgruppen i Endokrin Medisin, Haukeland universitetssykehus med prosjekter innenfor autoimmune sykdommer.
Publikasjoner
Konferanseforedrag
- Mona Synnøve Nilsen; Regine Åsen Jersin; Andre Madsen et al. (2018). Amino acid metabolism in adipocytes. (ekstern lenke)
- Mona Synnøve Nilsen; Carine Lindquist; Marit Hallvardsdotter Stafsnes et al. (2020). Low 3-hydroxyisobutyrate (3-HIB) and high methylmalonic acid (MMA) levels in plasma reflect increased hepatic fatty acid oxidation. (ekstern lenke)
- Mona Synnøve Nilsen; Regine Åsen Jersin; Adrian McCann et al. (2019). Circulating 3-hydroxyisobutyrate (3-HIB) as a clinical marker of prediabetes and T2D in patients with obesity. (ekstern lenke)
- Mona Synnøve Bjune; Laurence Lawrence-Archer; Simon N Dankel (2022). Nedbrytningen av BCAAs i humane leverceller er assosiert med fettleversykdom. (ekstern lenke)
- Mona Synnøve Bjune; Laurence Dyer; Matthias Blüher et al. (2021). Altered hepatic HIBCH expression is associated with hepatic lipid accumulation and fatty liver. (ekstern lenke)
- Regine Åsen Jersin; Divya Sri Priyanka Tallapragada; Mona Synnøve Nilsen et al. (2019). A novel amino acid transporter modulating insulin resistance via adipocytes . (ekstern lenke)
Vitenskapelig artikkel
- Mona Synnøve Nilsen; Regine Åsen Jersin; Arve Ulvik et al. (2020). 3-hydroxyisobutyrate, a strong marker of insulin resistance in type 2 diabetes and obesity that modulates white and brown adipocyte metabolism. (ekstern lenke)
- Mona Synnøve Nilsen; Carine Lindquist; Marit Hallvardsdotter Stafsnes et al. (2021). Plasma 3-hydroxyisobutyrate (3-HIB) and methylmalonic acid (MMA) are markers of hepatic mitochondrial fatty acid oxidation in male Wistar rats. (ekstern lenke)
- Regine Åsen Jersin; Divya Sri Priyanka Tallapragada; Andre Madsen et al. (2021). Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, Obesity and Insulin Resistance. (ekstern lenke)
- Mona Synnøve Bjune; Laurence Dyer; Johnny Laupsa-Borge et al. (2023). Metabolic role of the hepatic valine/3-hydroxyisobutyrate (3-HIB) pathway in fatty liver disease. (ekstern lenke)
- Regine Åsen Jersin; Divya Sri Tallapragada; Linn Skartveit et al. (2023). Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism. (ekstern lenke)
Konferanseposter
- Mona Synnøve Nilsen; Regine Åsen Jersin; Andre Madsen et al. (2019). Adipocyte amino acid metabolism in obesity-related metabolic diseases. (ekstern lenke)
- Regine Åsen Jersin; Mona Synnøve Nilsen; Divya Sri Priyanka Tallapragada et al. (2019). Inhibition of serine transporter SLC7A10 promotes lipid accumulation through altered BCAA catabolism in adipocytes. (ekstern lenke)
- Mona Synnøve Bjune; Laurence Dyer; Adrian McCann et al. (2022). Altered hepatic HIBCH expression is associated with hepatic lipid accumulation and fatty liver. (ekstern lenke)